<div id="readability-page-1"><div><p>GE HealthCare and Mayo Clinic announced the GE HealthCare-Mayo Clinic Initiative in Radiation Therapy, known as GEMINI-RT, an ambitious new collaboration that aims to transform personalized radiation therapy and cancer care. Building on decades of collaboration and the original Strategic Radiology Research Collaboration signed in 2023, GEMINI-RT plans to drive innovation in prediction, planning, automation, workflow and monitoring for radiation oncology. GEMINI-RT combines Mayo Clinic's world-class clinical and research expertise with GE HealthCare's leading technical and engineering innovation in oncology care and radiation therapy.</p><p>The initiative aims to deliver comprehensive, personalized care by exploring integrating imaging, advanced therapies, dosimetry, and patient monitoring at every step of the patient journey--from detection and diagnosis to treatment and follow-up. radiation therapy is a cornerstone of cancer care, used in more than 50% of cases worldwide and for over 2 million U.S. patients annually. Rising global cancer incidence, 19.3 million new cases in 2022, continues to drive demand for this treatment3.</p><p>Through GEMINI- RT, Mayo Clinic and GE HealthCare aim to make personalized radiation therapy accessible with new initiatives such as integrating streamlined, data-driven solutions, leveraging Mayo Clinic's clinical expertise and patient outcomes data. The collaboration will deepen efforts across four strategic areas: Automation: Collaborating on AI-powered solutions that can eliminate repetitive tasks and accelerate treatment planning; Predictive Oncology: Harnessing clinical insights to personalize cancer treatment decisions and improve outcomes; Multi-modal Therapies: Exploring approaches that combine radiation with emerging treatments like targeted drugs and precision heating for more effective care; Connected Care: Using AI, biomarkers, and sensors to monitor patients beyond the clinic--with the aim to predict side effects early and support treatment at home. GEMINI- RT Research and activities will be based at Mayo Clinic's campus in Rochester, Minnesota, leveraging both organizations' strengths in clinical practice, research, and product development.</p><p>This research initiative builds on the 2023 strategic radiology research alliance in which GE HealthCare and Mayo Clinic are collaborating on projects in advanced Magnetic Resonance (MR) technologies and techniques, theranostics treatment for cancer, and diagnostic and interventional ultrasound.</p></div></div>

GEHC

<p>GE HealthCare 和梅奥诊所推出了 GEMINI-RT，这是一个旨在推进个性化放射治疗和癌症护理的合作项目。该倡议旨在在放射肿瘤学领域进行预测、规划、自动化和监测的创新，结合梅奥诊所的临床专业知识与 GE HealthCare 的技术创新。GEMINI-RT 将重点关注自动化、预测性肿瘤学、多模式疗法和连接护理，利用人工智能和数据驱动的解决方案来增强治疗效果。该研究将在梅奥诊所的罗切斯特校区进行，基于他们 2023 年的战略放射学研究联盟</p>

GE Healthcare 和梅奥诊所推出 Gemini-Rt